All In MedTech

Device Trial Radar · NCT06565390

Remote Oximeter Monitoring Post-discharge to Reduce Emergency Room Visits and Rehospitalization

Remote Oximeter Monitoring Post-discharge to Reduce Emergency Room Visits and Rehospitalization (ROMPER): A Randomized Clinical Trial

Last checked: Nov 20, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitationPivotal-lookingRandomized with 700 participants. This is a heuristic, not a regulatory label.

Status

Enrolling by invitation

Enrollment

700

Planned (sponsor's estimate)

Start

Sep 11, 2025

Primary completion

Oct 31, 2027

Study completion Dec 31, 2030

Sponsor

Lead sponsor
University of Alabama at BirminghamAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Owlet Baby Care, Inc.
First posted
Aug 22, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Supportive care
FDA-regulated device
Yes
Who can join
All sexes, from 22 weeks, up to 6 months
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This randomized clinical trial will determine the efficacy of remote patient monitoring using an Owlet OSS 3.0 pulse oximeter for the reduction of emergency room visits and high-acuity rehospitalizations among high-risk infants after NICU discharge.

Conditions

  • Emergencies

Interventions

  • Babies in the Owlet monitor groupDevice

    The Owlet group will be given an Owlet OSS 3.0 monitor to wear when sleeping. The Owlet alarms if the baby has a very low heart rate or very low oxygen levels. In addition, caregivers in the Owlet group with a smart phone and Wi-Fi access will be able to use an application to monitor the baby's vital signs and sleep state.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Emergency room visits and high-acuity rehospitalizations.Time frame: 6 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.